期刊文献+

小鼠FOXP3-siRNA慢病毒载体的构建及其对小鼠动脉粥样硬化的影响 被引量:4

Construction of a recombinant lentivirus vctor siRNA targeting mouse FOXP3 gene and effects on the progression of the atherosclerosis plaque in mouse
原文传递
导出
摘要 目的:构建小鼠FOXP3基因特异性si RNA慢病毒载体,并对其进行功能性研究。方法:根据Gene-Bank提供的小鼠FOXP3cDNA序列,设计4条RNA干扰靶点序列,制备双链DNA oligo,与制备好的双酶切慢病毒载体连接,再转入细菌感受态细胞DH-5a,行PCR鉴定出阳性克隆并测序,制备成FOXP3-si RNA慢病毒载体,利用Western-blot方法对构建的载体进行功能性研究;将载体通过尾静脉注入小鼠体内,观察其对小鼠动脉粥样硬化形成的影响。结果:构建的小鼠FOXP3基因si RNA慢病毒载体,经PCR和DNA测序证实与设计完全一致,并对Foxp3+CD4+CD25+调节性T细胞有显著敲减效应;其能显著促进动脉粥样硬化形成。结论:体内外实验表明,成功构建了小鼠FOXP3基因的特异性si RNA慢病毒载体。 Objective:To construct a recombinant lentivirus vector RNAi targeting mouse FOXP3 gene and its effect on the progression of aortic atherosclerosis plaque in hypercholesterolemic apoliprotein(apo)E-/- mice. Method:siRNA of FOXP3 gene was designed according to the principle of RNAi-based medicine, and was converted into cDNA coding expression of small hairp in RNAs (shRNA) of siRNA, in total four siRNA sequence, and prepare double DNA oligo, to conjugate lentivirus vector enzymied by Hpa Ⅰ and Xho Ⅰ, and transfer into competent cell DH-5α, identified by PCR and sequence analysis. To construct FOXP3-siRNA lentivirus vector, we identify its function by Western-blot and inject through the tail vein to apoE-/- mice to observe its effect on atherosclerosis. Result:The recombinant lentivirus vector for RNAi targeting mouse FOXP3 gene is concord with our protocol by PCR and sequencing confirm. It can knock down mouse Foxp3^+ CD4^+ CD25^+ Treg cells effectively and in vivo It can promote significant the progression of the atherosclerosis plaque in apoE-/- mice. Conclusion:Our studies indicate that lentiviral siRNA can provide highly efficient and specific FOXP3 knockdown.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第2期149-151,共3页 Journal of Clinical Cardiology
基金 国家自然科学基金资助项目(No:C03030201)
关键词 动脉粥样硬化 FOXP3基因 RNA干扰 慢病毒载体 调节性T细胞 atherosclerosis FOXP3 gene RNAi lentivirus vector FOXP3^+CD4^+GD25^+Treg cell
  • 相关文献

参考文献7

二级参考文献31

共引文献26

同被引文献40

  • 1刘杰,高秀梅,王怡,张伯礼.三七总皂苷对心肌缺血大鼠血流动力学影响实验研究[J].天津中医药,2005,22(2):158-160. 被引量:27
  • 2魏永军,李国平,王瑞兰.补体及其抑制剂与心肌缺血/再灌注损伤[J].中国急救医学,2006,26(6):448-450. 被引量:3
  • 3Derek M,Yellon DS.Myocardial Reperfusion Injury[J].N Engl J Med,2007,357(11):1121-1135.
  • 4Ferdinandy P,Schulz R,Baxter GF.Interaction of cardiovascullar risk factors with myocardial ischemia/reperfusion injury,preconditioning and postconditoning[J].Pharmacol Rev,2007,59(4):418-458.
  • 5Yasojima K,Kilgore KS,Ashington RA,et al.Complement gene expression by rabbit heart:upregulation by ischemia and reperfusion[J].Circ Res,1998,82(11):1224-1230.
  • 6Collard CD,Vakeva A,Morrissey MA,et al.Complement activation after oxidative stress:role of the lectin complement pathway[J].Am J Pathol,2000,156(5):1549-1556.
  • 7Collard CD,Vakeva A,Morrissey MA,et al.Complement activation after oxidative stress:role of the lectin complement pathway[J].Am J Pathol,2000;156(5):1549-56.
  • 8Khvorova A,Reynolds A,Jayasenal SD.Functional siRNAs and miRNAs exhibit strand bias[J].Cell,2003;115(2):209-16.
  • 9Yesilbursa D,Serdar A,Senturk T,et al.Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction[J].Heart Vessels,2006;21(1):33-7.
  • 10World Health Organization. 2005. WHO Expert Committee on Ra-bies. 2004. First Report; WHO technical report series 931. World Health Organization. Geneva, Switzland.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部